1. Introduction {#sec1}
===============

First described in 1998 \[[@B1]\], Russell body gastritis (RBG) is a rare inflammatory condition characterized by abundant intramucosal polyclonal plasma cells, which contain intracytoplasmic, eosinophilic globules of immunoglobulins (Russell bodies) that displace the nucleus, with an accompanying chronic inflammatory infiltrate. It usually occurs in the gastric antrum, but two cases of Russell body duodenitis have been recently described. Herein, we report an unusual case of Barrett esophagus with prominent lymphoplasmacytic infiltration and Russell bodies, which expands the current spectrum of Russell body gastritis/duodenitis.

2. Case Report {#sec2}
==============

A 69-year-old male with a history of Barrett esophagus (6 cm length of involvement) underwent an ablation procedure, which resulted in a residual 1--1.5 cm band of Barrett mucosa ([Figure 1](#fig1){ref-type="fig"}) that was separated from the gastroesophageal junction by endoscopically unremarkable squamous mucosa. Two years later, biopsies from the residual band of Barrett mucosa showed intestinal metaplasia with active inflammation and numerous monomorphic cells in the lamina propria with eccentric nuclei and abundant eosinophilic cytoplasm ([Figure 2](#fig2){ref-type="fig"}). The monomorphic cells were highlighted by a periodic acid-Schiff (PAS) stain and immunohistochemical studies for CD79a, kappa, and lambda (Figures [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}, and [6](#fig6){ref-type="fig"}). There was no immunoreactivity with pan-cytokeratins (AE1/AE3). This immunohistochemical profile supported that these cells were polyclonal plasma cells, as seen in Russell body gastritis (RBG). The Barrett mucosa was called indefinite for dysplasia due to active inflammation.

3. Discussion {#sec3}
=============

Russell body gastritis/duodenitis is an unusual form of chronic gastrointestinal mucosal inflammation, characterized by abundant plasma cells containing eosinophilic cytoplasmic globules. Russell bodies represent a cellular response to overstimulation of plasma cells, leading to the accumulation of abundant, nondegradable, condensed immunoglobulin in dilated rough endoplasmic reticulum cisternae \[[@B2]\]. Plasma cells filled with abundant intracytoplasmic Russell bodies are called Mott cells, which can be seen in disease states characterized by plasmacytosis and chronic inflammation, such as chronic follicular gastritis, autoimmune-mediated diseases such as Hashimoto\'s thyroiditis and rheumatoid arthritis, and hematopoietic tumors with plasmacytic differentiation, such as MALT lymphoma, plasmacytoma, or lymphoplasmacytic lymphoma \[[@B3]\]. Mott cells are extremely rare in epithelial tumors. In gastrointestinal mucosal plasmacytic infiltrates, the absence of nuclear atypia, mitotic activity, lymphoepithelial lesions, and monoclonal infiltrates, favors a benign, reactive process, such as chronic inflammation.

Including our current case, there are 24 reported cases of Russell body gastritis, duodenitis, and Barrett esophagitis in the English medical literature ([Table 1](#tab1){ref-type="table"}) \[[@B1], [@B3]--[@B22]\]. The mean age of affected patients in these reports is 61 years (range 34--88 years), with a male-to-female ratio of 2.4 : 1. Most patients presented with nonspecific gastrointestinal symptoms, such as abdominal discomfort, nausea, and dyspepsia. Endoscopic features were likewise non-specific, including mucosal erythema, edema, erosion, ulceration, or, rarely, raised nodules. Biopsy specimens from all cases showed active chronic inflammation with either focal or diffuse accumulation of plasma cells containing Russell bodies. Of the 20 gastric cases, 12 showed evidence of *Helicobacter pylori* infection; all 4 extragastric (duodenal and esophageal) cases were *H. pylori* negative. Other associated conditions included HIV infection \[[@B9], [@B11], [@B16], [@B20]\], ethanol abuse \[[@B1], [@B5]\], gastric carcinoma \[[@B14], [@B19]\], Barrett esophagus \[[@B22]\], monoclonal gammopathy of uncertain significance \[[@B8]\], and concurrent Hepatitis C infection and insulin-dependent diabetes mellitus \[[@B17]\].

While plasmacytic infiltrates are the hallmark of gastric chronic inflammation, plasma cells containing Russell bodies are rare in *Helicobacter pylori*-associated gastritis. It is hypothesized that chronic *Helicobacter* infection stimulates plasma cell-driven hyperproduction of immunoglobulins, which leads to Russell body formation and Mott cell proliferation. The highly pathogenic *Helicobacter pylori*genotypes vacA and cagA may also be associated with RBG \[[@B23]\]. The disappearance of Russell bodies following successful *Helicobacter pylori* eradication therapy also supports the etiopathogenic role of the organism in RBG \[[@B1], [@B3], [@B7], [@B10], [@B11], [@B13], [@B15]\]. In 2006, Stewart and Spagnola reported three cases of *Helicobacter*-associated gastritis with crystalline plasma cell inclusions, which may represent another morphologic manifestation of immunoglobulin accumulation in response to chronic gastritis \[[@B24]\].

While RGB is usually a benign incidental finding associated with *Helicobacter* infection \[[@B1], [@B6], [@B11]\], it has also been described in association with gastric tubular \[[@B19]\] and signet ring cell \[[@B14]\] adenocarcinoma. Russell bodies are actually more frequently seen in normal tissues adjacent to malignant processes compared to benign conditions, which suggests a possible association between malignancy and Russell body formation \[[@B25]\]. Coexistence of gastric carcinoma and RBG is not entirely unexpected, given the frequent association between RBG and chronic *Helicobacter* infection---an established risk factor for gastric cancer.

In 2010, Shinozaki et al. \[[@B26]\] reported two cases of lymphoepithelioma-type, EBV-associated gastric carcinoma with extensive lymphoplasmacytic infiltration and prominent Mott cells \[[@B26]\]. EBER in situ hybridization highlighted the tumor cells obscured by the Mott cell proliferations, and the authors postulated that aberrant chemokine expression in the EBV-driven tumors led to plasma cell activation and subsequent Russell body formation and Mott cell proliferation. Although both cases also showed evidence of *H. pylori*infection, the Mott cell proliferations were confined to the mucosa involved by the tumors and were not seen in the background mucosa; thus, RBG was excluded.

Russell body duodenitis has recently been reported in two patients: a 55-year-old HIV-infected male \[[@B20]\] and a 69-year-old female \[[@B21]\] with autoimmune disease. In both cases, the Russell body infiltrates and chronic inflammation occurred in areas of duodenal gastric metaplasia and, notably, in the absence of demonstrable *Helicobacter* infection. In this setting, Russell body duodenitis may represent either the residual sequela of healed or partiallytreated gastric *Helicobacter* infection or an abnormal response to disordered systemic immune responses. In 2005, Rubio described Mott cells in Barrett esophagus \[[@B22]\]. To our knowledge, the current case is the second reported case of RBG in Barrett esophagus. Regardless of anatomic location, it is likely that chronic inflammation causes aberrant chemokine expression, resulting in overstimulation of plasma cells, excessive immunoglobulin production, and subsequent Russell body formation.

RBG represents a potential diagnostic pitfall because the distended plasma cells may be mistaken for signet ring tumor cells \[[@B4]\]. The plasma cells in RBG, however, lack nuclear atypia, mucicarmine, and cytokeratin expression. The periodic acid-Schiff reaction may help identify Russell bodies by conferring a dense, glassy stain to intracytoplasmic immunoglobulins. Plasma cell markers, such as CD138 and CD79a, and concomitant kappa and lambda light chain expression will demonstrate the polyclonal nature of the plasma cell infiltrate. Associated gastric carcinoma and infectious agents, such as *Helicobacter* and *Candida*, may alter patient management and clinical outcome and therefore should be excluded by ancillary studies.

The differential diagnosis for plasma cell infiltrates in the lamina propria of the luminal gastrointestinal tract including plasma cell neoplasms, such as plasmacytoma and mucosa-associated lymphoid tissue (MALT) lymphoma with plasmacytic differentiation. Benign Mott cell proliferations can be distinguished from hematopoietic malignancies by the absence of cellular atypia, mitotic activity, and monoclonality. Immunohistochemistry, in situ hybridization, and PCR for immunoglobulin heavy chain rearrangements aid in the evaluation of clonality.

The management of RBG involves *Helicobacter* eradication therapy and exclusion of associated conditions, including other infectious agents and gastric carcinoma.

In conclusion, we report the second case of Barrett esophagus with prominent lymphoplasmacytic infiltration and Russell bodies, which expands the current spectrum of Russell body gastritis/duodenitis. Given the various anatomic locations in which Russell body gastritis may arise, we suggest that "Russell body gastroenteritis" may be a more appropriate designation for this uncommon reactive condition.

![Upper endoscopy (esophagogastroduodenoscopy): a residual 1--1.5 cm band of salmon-pink Barrett mucosa separated from the gastroesophageal junction by endoscopically unremarkable squamous mucosa.](CRIM.MEDICINE2013-797264.001){#fig1}

![Hematoxylin and eosin, 20x. Biopsies from the Barrett mucosa showed intestinal metaplasia with active inflammation and numerous monomorphic cells in the lamina propria with eccentric nuclei and abundant eosinophilic cytoplasm.](CRIM.MEDICINE2013-797264.002){#fig2}

![Periodic acid-Schiff-Alcian blue stain (pH 2.5), 20x. The monomorphic cells were highlighted by a periodic acid-Schiff (PAS) stain; note the dark blue inhomogeneous staining of intracytoplasmic mucin in the intestinal-type metaplastic goblet cells, which is characteristic in Barrett mucosa.](CRIM.MEDICINE2013-797264.003){#fig3}

![CD79a immunostain, 20x. The distended protein-containing cells in the lamina propria are highlighted by CD79a, a plasma cell marker.](CRIM.MEDICINE2013-797264.004){#fig4}

![Kappa light chain immunostain, 20x. The Russell body-laden plasma cells show both kappa and lambda (i.e., polyclonal) immunoglobulin expression.](CRIM.MEDICINE2013-797264.005){#fig5}

![Lambda light chain immunostain, 40x. The Russell body-laden plasma cells show both kappa and lambda (i.e., polyclonal) immunoglobulin expression.](CRIM.MEDICINE2013-797264.006){#fig6}

###### 

Reported cases of Russell body gastritis, duodenitis, and Barrett esophagus.

  Case   Authors                                 Age/sex   Location    *H. pylori* infection   Other conditions                                                       Country
  ------ --------------------------------------- --------- ----------- ----------------------- ---------------------------------------------------------------------- -----------
  1      Yu et al. 1987 \[[@B4]\]                65/F      Stomach     Unknown                 Unknown                                                                Korea
  2      Tazawa and Tsutsumi 1998 \[[@B1]\]      53/M      Stomach     Yes                     Ethanol abuse                                                          Japan
  3      Erbersdobler et al. 2004 \[[@B5]\]      83/F      Stomach     No                      Esophageal candidiasis, ethanol abuse                                  Germany
  4      Ensari et al. 2005 \[[@B6]\]            70/M      Stomach     Yes                     ---                                                                    Turkey
  5      Paik et al. 2006 \[[@B7]\]              47/F      Stomach     Yes                     ---                                                                    Korea
  6      Paik et al. 2006 \[[@B7]\]              53/F      Stomach     Yes                     ---                                                                    Korea
  7      Wolkersdörfer et al. 2006 \[[@B8]\]     54/M      Stomach     Yes                     MGUS                                                                   Germany
  8      Drut and Olenchuk 2006 \[[@B9]\]        34/M      Stomach     No                      HIV+                                                                   Argentina
  9      Pizzolitto et al. 2007 \[[@B10]\]       60/F      Stomach     Yes                     ---                                                                    Italy
  10     Eum et al. 2007 \[[@B3]\]               48/M      Stomach     Yes                     Colonic polyps                                                         Korea
  11     Licci et al. 2009 \[[@B11]\]            59/M      Stomach     Yes                     HIV+                                                                   Italy
  12     Habib et al. 2010 \[[@B12]\]            75/M      Stomach     No                      Renal failure, dyslipidemia, ethanol abuse, and prior rhabdomyolysis   USA
  13     Del Gobbo et al. 2011 \[[@B13]\]        78/F      Stomach     No                      ---                                                                    Italy
  14     Wolf et al. 2011 \[[@B14]\]             67/M      Stomach     Yes                     Signet ring cell carcinoma                                             Austria
  15     Yoon et al. 2012 \[[@B15]\]             57/M      Stomach     Yes                     Gastric & colonic polyps                                               Korea
  16     Yoon et al. 2012 \[[@B15]\]             43/M      Stomach     Yes                     ---                                                                    Korea
  17     Bhalla et al. 2012 \[[@B16]\]           82/M      Stomach     No                      HIV+                                                                   USA
  18     Coyne and Azadeh 2012 \[[@B17]\]        49/M      Stomach     No                      Hepatitis C+, IDDM                                                     UK
  19     Karabagli and Gokturk 2012 \[[@B18]\]   60/M      Stomach     Yes                     ---                                                                    Turkey
  20     Choi et al. 2012 \[[@B19]\]             55/M      Stomach     Yes                     Gastric adenocarcinoma                                                 Korea
  21     Savage et al. 2011 \[[@B20]\]           55/M      Duodenum    No                      HIV+, lymphoma                                                         USA
  22     Mondolfi et al. 2012 \[[@B21]\]         69/F      Duodenum    No                      Crohn\'s disease, cirrhosis, rheumatoid arthritis, and obesity         USA
  23     Rubio 2005 \[[@B22]\]                   88/M      Esophagus   No                      Barrett esophagus                                                      Sweden
  24     Bhaijee et al.                          71/M      Esophagus   No                      Barrett esophagus                                                      USA
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